H 
Haleon HLN.L · GBp
Consumer Staples · Personal Care Products · LSE · 🇬🇧 United Kingdom
FTSE 100
330.80p
-2.39%
Close of 9 Nov 2026, in pence
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in GBP, from our data supplier.
Revenue
£11.03bn
FY2019FY2025
Net income
£1.67bn
FY2019FY2025
Free cash flow
£2.02bn
FY2019FY2025
Shareholders' equity
£16.43bn
FY2019FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | £11.03bn | £11.23bn | £11.30bn | £10.86bn | £9.54bn | £9.89bn | £8.48bn |
| Gross profit | £7.14bn | £6.82bn | £6.75bn | £6.73bn | £5.95bn | £5.91bn | £4.80bn |
| Research and development | £315.0m | £298.0m | £311.0m | £300.0m | £257.0m | £304.0m | £292.0m |
| Operating income | £2.48bn | £2.21bn | £2.00bn | £1.82bn | £1.64bn | £1.60bn | £897.0m |
| Net income | £1.67bn | £1.44bn | £1.05bn | £1.06bn | £1.39bn | £1.15bn | £655.0m |
| Diluted earnings per share | 0.19 | 0.16 | 0.11 | 0.11 | 0.15 | 0.13 | 0.07 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total assets | £32.63bn | £34.31bn | £34.05bn | £34.81bn | £34.45bn | £34.13bn | £35.71bn |
| Cash and short-term investments | £1.32bn | £2.19bn | £1.04bn | £684.0m | £414.0m | £334.0m | £340.0m |
| Total liabilities | £16.15bn | £18.09bn | £17.33bn | £18.36bn | £7.97bn | £7.91bn | £8.30bn |
| Debt | £8.60bn | £10.13bn | £9.46bn | £10.44bn | £991.0m | £487.0m | £642.0m |
| Shareholders' equity | £16.43bn | £16.17bn | £16.61bn | £16.33bn | £26.36bn | £26.11bn | £27.32bn |
| Shares outstanding | 8,988m | 9,185m | 9,248m | 9,235m | 9,235m | 8,920m | 8,920m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | £2.34bn | £2.30bn | £2.10bn | £2.06bn | £1.36bn | £1.41bn | £786.0m |
| Capital spending | −£322.0m | −£318.0m | −£336.0m | −£328.0m | −£298.0m | −£318.0m | −£243.0m |
| Free cash flow | £2.02bn | £1.98bn | £1.76bn | £1.74bn | £1.06bn | £1.09bn | £543.0m |
| Dividends paid | −£612.0m | −£570.0m | −£388.0m | −£2.68bn | −£1.15bn | −£2.37bn | −£1.15bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | £2.80bn | £2.80bn | £2.77bn | £2.77bn | £2.74bn | £2.74bn | £2.76bn | £2.78bn |
| Gross profit | £1.85bn | £1.85bn | £1.80bn | £1.80bn | £1.77bn | £1.77bn | £1.53bn | £1.75bn |
| Operating income | £586.0m | £586.0m | £604.5m | £604.5m | £601.5m | £601.5m | £350.0m | £705.0m |
| Net income | £381.0m | £381.0m | £430.5m | £430.5m | £403.0m | £403.0m | £231.0m | £485.0m |
| Diluted earnings per share | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 | 0.05 |
| Cash from operations | £522.0m | £522.0m | £239.0m | £239.0m | £513.0m | £513.0m | — | — |
| Capital spending | −£55.0m | −£55.0m | −£113.0m | −£113.0m | −£48.0m | −£48.0m | — | — |
| Free cash flow | £467.0m | £467.0m | £126.0m | £126.0m | £465.0m | £465.0m | — | — |
| Total assets | £32.58bn | £32.58bn | £32.63bn | £32.60bn | £31.83bn | £31.83bn | £34.31bn | — |
| Cash and short-term investments | £826.0m | £826.0m | £1.32bn | £1.32bn | £676.0m | £676.0m | £2.19bn | £531.0m |
| Debt | £1.96bn | £1.96bn | £8.50bn | £837.0m | £8.42bn | £866.0m | £10.03bn | — |
| Shareholders' equity | £16.38bn | £16.38bn | £16.43bn | £16.43bn | £15.94bn | £15.94bn | £16.17bn | £16.71bn |
Financial ratios
Data as of 21 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 64.8% | 60.7% | 59.7% | 62.0% | 62.3% | 59.7% |
| Operating margin | 22.4% | 19.6% | 17.7% | 16.8% | 17.2% | 16.2% |
| Net margin | 15.1% | 12.8% | 9.3% | 9.8% | 14.6% | 11.6% |
| Return on equity | 10.1% | 8.9% | 6.3% | 6.5% | 5.3% | 4.4% |
| Return on assets | 5.1% | 4.2% | 3.1% | 3.0% | 4.0% | 3.4% |
| Free cash flow yield | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | — |
| Revenue growth | -1.8% | -0.6% | 4.1% | 13.8% | -3.5% | 16.7% |
| Earnings growth | 15.6% | 37.5% | -1.0% | -23.7% | 21.4% | 74.8% |
| Current ratio | 0.92x | 0.98x | 1.04x | 0.93x | 1.24x | 1.25x |
| Debt to equity | 0.52x | 0.62x | 0.57x | 0.63x | 0.03x | 0.01x |
| Equity ratio | 50.3% | 47.1% | 48.8% | 46.9% | 76.5% | 76.5% |
| Interest coverage | 7.28x | 5.46x | 4.82x | 6.47x | 117.00x | 79.90x |
| R&D as a share of sales | 2.9% | 2.7% | 2.8% | 2.8% | 2.7% | 3.1% |
| Buybacks as a share of market value | 2.1% | 0.7% | -0.1% | 0.0% | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 0.1% | 1.6% | — |
| Operating income | 10.7% | 9.1% | — |
| Net income | 16.3% | 7.8% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 62.7% | 61.8% | 61.5% | — |
| Operating margin | 21.0% | 19.1% | 18.4% | — |
| Net margin | 14.0% | 11.7% | 12.1% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Price to earnings | 20.2 | 24.0 | 28.4 | 28.5 |
| Price to sales | 3.2 | 3.2 | 2.7 | 2.8 |
Dividends and splits
Per share, in the currency the company pays
Paid for 3 years. Last went ex-dividend on 13 Aug 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Paid in the year | 0.073 | 0.068 | 0.062 | 0.042 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.